Innovation
Drug from BergenBio in clinical trial against COVID-19
UiB spin-off biotech company BergenBio announced that their drug bemcentinib is frast-tracked in a phase-II clinical trial as a potential treatment against COVID-19.
Foto/ill.:
colorbox
Hovedinnhold
Publisert: 15.05.2020
Read more in norwegian here:
https://www.uib.no/med/135554/bergenbio-legemiddel-kan-bli-korona-medisin
Relevant links